SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
RNAi
An SI Board Since May 2003
Posts SubjectMarks Bans
671 52 0
Emcee:  tuck Type:  Unmoderated
Introduction Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
471Off to a good start. They need to show some improvement in visual acuity, and ttuck-8/10/2006
470Greetings, all. Sirna releases P1 results for AMD candidate Sirna-027. phx.cThomas-8/10/2006
469Looks like ISIS has a promising ALS treatment coming along... Public release daIan@SI-7/27/2006
468srpharma.comzeta1961-6/29/2006
467June 20, 2006, NYT DNA or RNA? Versatile Player Takes a Leading Role in Moleculzeta1961-6/21/2006
466Alnylam Receives Issued U.S. Patent Broadly Covering RNAi Therapeutics Tuesday Jnigel bates-6/6/2006
465Mice Deaths Are Setback in Gene Test [NYT] By ANDREW POLLACK Published: May 25,Doc Bones-5/26/2006
46404:01 ET Sigma-Aldrich and Rosetta Impharmatics establish partnership for siRNA Ian@SI-5/23/2006
463<b>Gold nanoparticles could improve antisense cancer drugs</b> PublIan@SI-5/18/2006
462RNAi update article follows. Pipeline filling up. Cheers, Thomas RNA interfereThomas-5/9/2006
461<b>Interfering RNA silences genes in 'slippery' immune cells NovelIan@SI-5/8/2006
460<i>This is a patent for a target via this technology, not the technology pA.J. Mullen-4/5/2006
459This is a patent for a target via this technology, not the technology platform. tuck-4/5/2006
458>>wish I knew the truth<< Look at how long the IP struggles lasted nigel bates-4/5/2006
457<i>"We are gratified that the US Patent Office has issued the first bA.J. Mullen-4/5/2006
456Thanks, Nigel. Looks like $6mm of the $12mm is a stock purchase, FWIW. I guessThomas-4/3/2006
455Sirna Therapeutics Granted First Broad siRNA Patent for a Gene Target in the Uninigel bates-4/3/2006
454GlaxoSmithKline and Sirna Therapeutics Announce Major Alliance in RNAi-Based Thenigel bates-4/3/2006
453June last year. INGN took an 8% stake in the related financing (SR is a minnow)nigel bates-3/29/2006
452Lawsuit over delivery technology from Protiva. Cheers, Thomas Protiva BiotherapThomas-3/29/2006
451Thanks, Nigel. Interesting that Atugen is now a subsidiary of SR Pharma. WondeThomas-3/29/2006
450"RNAi" Video on Request from Cambridge Healthtech Institute: discoverCambridge Healthtech-3/28/2006
449SR Pharma plc announces Licence with Merck & Co. <pre>nigel bates-3/28/2006
448BIOM is attempting to develop a cancer vaccine (BLP-25) which uses a liposome asIan@SI-3/27/2006
447Followup announcement from ALNY: Alnylam Announces New Collaboration and AgreemThomas-3/27/2006
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News